GSK (GSK)

NYSE: GSK · Real-Time Price · USD

38.76

-1.09 (-2.74%)

At close: May 01, 2025, 3:59 PM

38.72

-0.09%

After-hours: May 01, 2025, 06:32 PM EDT

GSK Cash Flow Statement

Financials in GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	2.95B	4.93B	4.92B	5.1B	6.39B	5.27B	4.05B	2.17B	1.06B
Depreciation & Amortization	2.55B	2.29B	2.3B	2.52B	624M	3B	1.76B	2.98B	1.86B
Stock-Based Compensation	344M	307M	346M	343M	337M	365M	360M	333M	319M
Other Working Capital	2.04B	247M	662M	435M	159M	160M	-298M	-276M	-92M
Other Non-Cash Items	-1.38B	945M	351M	756M	848M	814M	717M	669M	664M
Deferred Income Tax	n/a	-865M	-784M	-318M	80M	-1.95B	1.78B	1.5B	2.61B
Change in Working Capital	2.09B	-841M	271M	-473M	120M	531M	-247M	-737M	-22M
Operating Cash Flow	6.55B	6.77B	7.4B	7.95B	8.44B	8.02B	8.42B	6.92B	6.5B
Capital Expenditures	-2.98B	-2.34B	-2.26B	-2.93B	-2.24B	-2.16B	-1.8B	-2.2B	-2.35B
Cash Acquisitions	1.37B	-1.47B	-3.14B	185M	3.01B	-3.78B	-292M	356M	592M
Purchase of Investments	n/a	n/a	-144M	1.76B	-1M	-258M	-309M	4M	-928M
Sales Maturities Of Investments	21M	72M	1M	18M	3.27B	1M	-452M	4M	683M
Other Investing Acitivies	-1.22B	1.11B	-3.23B	-808M	-1.88B	846M	1.3B	395M	736M
Investing Cash Flow	-1.23B	-1.59B	-8.77B	-1.78B	2.16B	-5.35B	-1.55B	-1.44B	-1.27B
Debt Repayment	-1.17B	-2.37B	-771M	-2B	-4.01B	3.73B	8.15B	-990M	-18M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-65M	-74M
Dividend Paid	-2.44B	-2.25B	-3.47B	-4B	-3.98B	-3.95B	-3.93B	-3.91B	-4.85B
Other Financial Acitivies	-1.14B	-1.03B	5.06B	-1.61B	-2.18B	-1.67B	-10.69B	-1.48B	-1.45B
Financial Cash Flow	-4.73B	-5.64B	823M	-7.59B	-10.13B	-1.84B	-6.39B	-6.38B	-6.39B
Net Cash Flow	545M	-567M	-394M	-1.44B	431M	744M	487M	-1B	-881M
Free Cash Flow	3.57B	4.42B	5.14B	5.02B	6.2B	5.86B	6.63B	4.72B	4.14B